Physician profile
Robert J White
NPI 1093884033
$4,632.92
in general payments reported to CMS, 2019-2025
27 companies · $1,846 in 2025
The $1,846 reported for 2025 was more than what 82% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,033 · 2020: $93.46 · 2021: $239 · 2022: $32.61 · 2023: $1,207 · 2024: $181 · 2025: $1,846.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,719 · Food and Beverage: $1,515.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,719.28 |
| Food and Beverage | $1,514.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Voom Medical Devices, INC. | $1,041.24 | 2025 | Revcon Instrument Kit, Sterile |
| Arthrex, INC. | $784.16 | 2019-2023 | |
| Cgg Medical INC | $715.21 | 2023 | |
| Wright Medical Technology, INC. | $278.99 | 2019 | |
| Stryker Corporation | $178.25 | 2025 | Limflow System, Easyfuse |
| Paragon 28, INC. | $175.23 | 2019-2025 | Monkey Rings |
| Smith+Nephew, INC. | $173.14 | 2019-2025 | Bone Anchors With Arthroscopic Delivery System, Q-Fix |
| Horizon Therapeutics Plc | $170.35 | 2019-2021 | |
| Paratek Pharmaceuticals, INC. | $143.49 | 2025 | Nuzyra |
| Orthofix Medical, INC. | $124.68 | 2021-2025 | Physio-Stim |
| Organogenesis INC. | $112.75 | 2019 | |
| Amgen INC. | $105.51 | 2024-2025 | Krystexxa, Evenity, Prolia |
| Osteomed LLC | $102.40 | 2019 | |
| Kyowa Kirin, INC. | $93.40 | 2025 | |
| Integra Lifesciences Corporation | $67.21 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ani Pharmaceuticals, INC. | $63.28 | 2025 | Purified Cortrophin Gel |
| Merck Sharp & Dohme LLC | $57.99 | 2019-2025 | Zerbaxa |
| Janssen Biotech, INC. | $48.85 | 2024-2025 | Tremfya |
| Melinta Therapeutics, LLC | $28.74 | 2019 | |
| Reprise Biomedical, INC. | $28.67 | 2024 | Miro3d |
| Genzyme Corporation | $26.56 | 2025 | |
| Abbvie INC. | $25.02 | 2024 | |
| Convatec INC. | $19.41 | 2024 | |
| Djo, LLC | $18.26 | 2025 | Cmf |
| Aimmune Therapeutics, INC. | $18.13 | 2024 | |
| Bioventus LLC | $18.05 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $13.95 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.